1. Division of Pediatric Hematology/Oncology, Central Michigan University School of Medicine, Detroit, MI;
2. Louis Pradel Cardiology Hospital, Lyon 1 University, Lyon, France;
3. Genentech, Inc, South San Francisco, CA;
4. F. Hoffmann-La Roche Ltd, Basel, Switzerland;
5. School of Pathology, University of the Witwatersrand and National Health Laboratory Service (NHLS), Johannesburg, South Africa;
6. Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;
7. Department of Hematology, University of Washington, Seattle, WA;
8. Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy;
9. F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada;
10. Nara Medical University Hospital, Kashihara, Japan;
11. Hospital Universitario La Paz, Autonoma University, Madrid, Spain;
12. Department of Pathology, University of Michigan, Ann Arbor, MI; and
13. Department of Immunohaematology and
14. Department of Molecular Haemostasis, University of Bonn, Bonn, Germany